NASDAQ: AVDL - Avadel Pharmaceuticals plc

Yield per half year: -25.92%
Sector: Healthcare

Share chart Avadel Pharmaceuticals plc

Extended chart Simple chart
Financial Markets by TradingView

About

Avadel Pharmaceuticals plc работает как биофармацевтическая компания в США. Его ведущим продуктом-кандидатом является LUMRYZ, состав оксибата натрия, который находится в фазе 3 клинических испытаний для лечения чрезмерной дневной сонливости или катаплексии у взрослых с нарколепсией. Компания, ранее известная как Flamel Technologies SA, сменила название на Avadel Pharmaceuticals plc в январе 2017 года. Avadel Pharmaceuticals plc была зарегистрирована в 2015 году, ее штаб-квартира находится в Дублине, Ирландия.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Выручка 0.0592
EBITDA -0.0143
EV/EBITDA -26.69
P/E 52.22
P/S 4.52
Цена ао 16.81
P/BV -9.17
Сайт https://www.avadel.com
ISIN US05337M1045
Число акций ао 0.08017 млрд
Валюта usd
IPO date 1996-06-07
Sector Health Care
Industry Pharmaceuticals
Валюта отчета usd
Change price per day: 0% (13.12)
Change price per week: +2.66% (12.78)
Change price per month: -4.23% (13.7)
Change price per 3 month: -22.41% (16.91)
Change price per half year: -25.92% (17.71)
Change price per year: +15.09% (11.4)
Change price per 3 year: +31.2% (10)
Change price per 5 year: +496.36% (2.2)
Change price per year to date: +22.16% (10.74)
All parameters

Underestimation

Title Value Grade
P/S 39.57 1
P/BV 12.61 1
P/E 0 0
EV/EBITDA -8.16 0
Total: 3

Efficiency

Title Value Grade
ROA, % -61.38 0
ROE, % -182.67 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.26 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -72.92 0
Yield Ebitda, % 848.97 10
Yield EPS, % 125.04 10
Total: 8
More

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Neuroscience and Healthcare ETF 2.25833 19.720292847757 0.03
iShares Morningstar Small-Cap ETF 0.0271 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.0533 33.628071953382 0.72598
iShares Russell 2000 Growth ETF 0.09093 38.042556988 0.6026
iShares Russell 3000 ETF 0.00222 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.0271 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.0533 680.05582339508 0.72598
Principal Healthcare Innovators ETF 0.12494 618.4964157054 0.8416
Future Tech ETF 0.12494 426.33969118983 0.8416



Head Job title Payment Year of birth
Mr. Gregory J. Divis Jr. CEO & Director 753.69k 1967 (57 years)
Mr. Thomas S. McHugh Senior VP, Principal Financial and Accounting Officer & CFO 526k 1965 (59 years)
Mr. Richard J. Kim Chief Commercial Officer 548.44k 1969 (55 years)
Mr. Jerad G. Seurer General Counsel & Company Secretary N/A 1973 (51 year)
Mr. Gregory J. Davis VP of Corporate and Business Development N/A 1965 (59 years)
Mr. Mark W. Elrod Vice President of Sales N/A
Ms. Angie Woods Vice President of People & Culture N/A
Dr. Jordan S. Dubow M.D. Consultant 727.93k 1978 (46 years)
Dr. Jason M. Vaughn Senior Vice President of Technical Operations N/A
Ms. Jennifer Gudeman PharmD Senior Vice President of Medical & Clinical Affairs N/A

Address: Ireland, Dublin, 10 Earlsfort Terrace - open in Google maps, open in Yandex maps
Website: https://www.avadel.com